Pharma.MT Ltd.

Exact Sciences and distribution partner LabCorp are launching a new molecular colon cancer screening test. They've taken dx dealmaking to a new level but now they have to deliver on their promises. By

For some, it further separates the haves and have-nots. For others, it's an addictive drug for coping with chronic insufficiency syndrome. by Roger Longman All roads in 1998, it sometimes seemed, led

As Amgen Inc. created the model of the successful, fully integrated biotech company, Incyte Pharmaceuticals Inc. has done the same for the biotech service business. Selling its data non-exclusiv

A simple idea for handling DNA—that no one else ever thought of—may help Mosaic expand the market for PCR-based diagnostic testing. To many eyes, the current $200 million market for DNA diagnostic tes